Related Experiment Videos
Cold ischemia time and renal allograft function in cyclosporine-treated patients
B Eklund1, K Höckerstedt, H Isoniemi
1IV Department of Surgery, Helsinki University Central Hospital, Finland.
Transplantation Proceedings
|June 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
The British journal of surgery·2021
Histologically Verified Biliary Invasion was Associated with Impaired Liver Recurrence-Free Survival in Resected Colorectal Cancer Liver Metastases.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2018
Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Long-term outcomes of patients with 10 or more colorectal liver metastases.
British journal of cancer·2017
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Apoptosis-Related Molecular Signatures in Calcineurin Inhibitor Nephrotoxicity After Kidney Transplantation.
Transplantation proceedings·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026